ClearPoint Neuro, Inc. Common Stock
CLPTStock
$15.06+34.68%52W
Market Cap$471.74M
P/E—
Div yield—
Beta1.23
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-4.16%
Price vs S&P 500 (4W)18.44%
VGM Score56.36
Market Capitalization$471.74M
Earnings Surprise History
Q1 26-0.32est. -0.28
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.13
4.13
4.22
4.22
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CLPTClearPoint Neuro, Inc. Common Stock | F | A | B | $15.06 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
ClearPoint Neuro develops and commercializes minimally invasive surgical platforms for brain and cardiac procedures guided by real-time MRI imaging. The company's flagship ClearPoint system is currently in commercial use and addresses a significant market need for precise, image-guided neurosurgery. Revenue is generated through system sales, services, disposables, and software solutions.